DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, C. A.
Right arrow Articles by Slattery, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, C. A.
Right arrow Articles by Slattery, J. T.

0090-9556/97/2510-1150-1156$02.00/0
DRUG METABOLISM AND DISPOSITION
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics
Vol. 25, No. 10


ARTICLE
Mechanism of Cytochrome P450 Activation by Caffeine and 7,8-Benzoflavone in Rat Liver Microsomes

Caroline A. Lee, Peter T. Manyike, Kenneth E. Thummel, Sidney D. Nelson, and John T. Slattery

Departments of Pharmaceutics (C.A.L., P.T.M., K.E.T, J.T.S.) and Medicinal Chemistry, School of Pharmacy (S.D.N.), University of Washington, and the Fred Hutchinson Cancer Research Center (J.T.S.)

Caffeine and 7,8-benzoflavone activate CYP3A2 in rat liver microsomes. Both activators appear to enhance enzyme activity by an increase in Vmax and to a lesser extent a decrease in Km. Additive effect studies demonstrated that the two activators oppose one another's effect. Electron transfer steps in the cytochrome P450 cycle are involved in the mechanism of cytochrome P450 activation, as indicated by the lack of effect of caffeine or 7,8-benzoflavone on cumene hydroperoxide-supported oxidation of acetaminophen by cytochrome P450. The involvement of cytochrome b5 in the formation of N-acetyl-p-benzoquinone imine (NAPQI) was implicated through a synergistic effect of NADH on the NADPH-supported reaction. Anti-cytochrome b5, but not anti-cytochrome P450 reductase IgG, diminished the activation effect of caffeine on NAPQI formation. Neither antibody altered the effect of 7,8-benzoflavone on NAPQI formation. The impairment of NAPQI formation by cytochrome b5 antibody suggests that cytochrome P450 activation by caffeine but not 7,8-benzoflavone is mediated in part through enhancement of the transfer of the second electron to cytochrome P450 from cytochrome b5.

Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
J. M. Hutzler and T. S. Tracy
Atypical Kinetic Profiles in Drug Metabolism Reactions
Drug Metab. Dispos., April 1, 2002; 30(4): 355 - 362.
[Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. R. Winter, Y. Wang, and J. D. Unadkat
CYP2C8/9 Mediate Dapsone N-Hydroxylation at Clinical Concentrations of Dapsone
Drug Metab. Dispos., August 1, 2000; 28(8): 865 - 868.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. E. Witherow and J. B. Houston
Sigmoidal Kinetics of CYP3A Substrates: An Approach for Scaling Dextromethorphan Metabolism in Hepatic Microsomes and Isolated Hepatocytes to Predict In Vivo Clearance in Rat
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 58 - 65.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.